141895-35-4

Basic information

• Product Name: BOC-DL-TYR(ME)-OH
• Synonyms: 2-TERT-BUTOXYCARBONYLAMINO-3-(4-METHOXY-PHENYL)-PROPIONIC ACID;BOC-4-METHOXY-DL-PHENYLALANINE;BOC-4-METHOXY-DL-PHE-OH;BOC-4-METHOXYPHENYLALANINE;BOC-DL-TYR(ME)-OH;BOC-DL-TYROSINE(ME)-OH;BOC-DL-PHE(4-OME)-OH;BOC-DL-PHE(ME)-OH
• CAS NO: 141895-35-4
• Molecular Formula: C₁₅H₂₁NO₅
• Molecular Weight: 295.33
• Mol File: 141895-35-4.mol

Chemical Properties

• Boiling Point: 462°C at 760 mmHg
• Flash Point: 233.2°C
• Appearance: /
• Density: 1.168g/cm³
• Vapor Pressure: 2.47E-09mmHg at 25°C
• Refractive Index: 1.522
• Storage Temp.: 2-8°C
• CAS DataBase Reference: BOC-DL-TYR(ME)-OH(CAS DataBase Reference)
• NIST Chemistry Reference: BOC-DL-TYR(ME)-OH(141895-35-4)
• EPA Substance Registry System: BOC-DL-TYR(ME)-OH(141895-35-4)

Safety Data

• Hazardous Substances Data: 141895-35-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
BOC-DL-TYR(ME)-OH is used as an intermediate for the synthesis of amino acids and peptides, which are essential building blocks for various biologically active molecules and therapeutic agents. Its role in the pharmaceutical industry is crucial for the development of new drugs and the improvement of existing ones.
Used in Chemical Industry:
In the chemical industry, BOC-DL-TYR(ME)-OH is utilized as a key component in the production of various chemical compounds and materials. Its unique properties allow it to be used in the synthesis of a wide range of products, from specialty chemicals to advanced materials with specific applications.
Used in Research and Development:
BOC-DL-TYR(ME)-OH is also employed in research and development settings, where it is used to study the properties and functions of amino acids and peptides. This helps scientists gain a better understanding of their structure, function, and potential applications in various fields, including medicine, biotechnology, and materials science.
Overall, BOC-DL-TYR(ME)-OH is a versatile compound with a wide range of applications across different industries, primarily due to its role as an intermediate in the synthesis of amino acids and peptides. Its chemical properties and white appearance make it a valuable asset in the development of new products and technologies.

InChI:InChI=1/C15H21NO5/c1-15(2,3)21-14(19)16-12(13(17)18)9-10-5-7-11(20-4)8-6-10/h5-8,12H,9H2,1-4H3,(H,16,19)(H,17,18)

Upstream product

• 142847-18-5 N-(tert-butoxycarbonyl)tyrosine 
• 77-78-1 dimethyl sulfate 
• 556-02-5 ?Tyr 
• 74-88-4 methyl iodide 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 20989-19-9 2-amino-3-(4-methoxyphenyl)-1-propanol 
• 1429867-92-4 1-benzyl-N-cyclohexyl-5-(4-methoxybenzyl)-3-(4-methoxyphenyl)-6-oxo-1,6-dihydropyrazine-2-carboxamide 
• 60008-09-5 methyl2-(2-{[(tert-butoxy)carbonyl]amino}-3-(4-methoxyphenyl)propanamido)-3-hydroxypropanoate 
• 7635-29-2 O-methyl tyrosine 

Relevant articles and documents

Synthesis of l - Epi -capreomycidine derivatives via C-H amination

The l-epi-capreomycidine (Cpm) derivatives were efficiently and stereoselectively synthesized via nitrene C-H insertion starting from a readily available d-Tyr. Design of a substrate that takes into account hydrogen bonding is a critical feature in order

Preparation method of O-methyl-threonine/tyrosine

The invention relates to a preparation method of O-methyl-threonine/tyrosine. The preparation method mainly overcomes the disadvantages of the existing method that a toxic reagent is volatile, the reagent is dangerous, the steps are long, the yield is low, and the like. The preparation method of the O-methyl-threonine/tyrosine comprises the following steps: N-t-butyloxycarboryl-threonine/tyrosineis catalyzed by sodium hydroxide and reacts with dimethyl sulfate to generate N-t-butyloxycarboryl-O-methyl-threonine/tyrosine, and then t-butyloxycarboryl is removed from the N-t-butyloxycarboryl-O-methyl-threonine/tyrosine through acid substances to obtain the product O-methyl-threonine/tyrosine. The product has important application in the fields of antibiotics and polypeptide drugs.